SGT-212 has received FDA Fast Track, Rare Pediatric Disease and Orphan Drug designations - - Dosing of the first participant ...
About the FALCON Trial FALCON is a first-in-human, open-label, multi-center Phase 1b clinical trial designed to evaluate the safety and tolerability of SGT-212 in participants aged 18-40 who have been ...
FDA-cleared AI-CVD® extracts preventive insights from routine CT—identifying hidden cardiovascular, metabolic, and ...
Solid Biosciences Inc. (Nasdaq: SLDB) (the "Company" or "Solid"), a life sciences company developing precision genetic medicines for neuromuscular ...
Everyday Health on MSN
Obstructive vs. nonobstructive hypertrophic cardiomyopathy (HCM): What your diagnosis means for treatment and lifestyle
Learn the key differences between obstructive and nonobstructive HCM, including how your specific diagnosis can impact ...
News-Medical.Net on MSN
Male endurance athletes aged over 50 may be at greater risk of serious heart problems
Veteran male athletes who have spent years training at high intensity may be at greater risk of serious heart problems while ...
Fitgurú on MSN
Independence Gym Scottsdale: The Old-School Bodybuilding Mecca Powering Arizonas Elite
In the heart of Scottsdale, Arizona, a no-nonsense training facility is redefining what serious fitness looks like—blending ...
Protein timing has long been debated, but new evidence suggests total daily intake matters more than when you eat it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback